X

Umbralisib, a Dual PI3Kδ/CK1ε Inhibitor in Patients with Relapsed/Refractory Indolent Lymphoma

Drug Category: Array
Conference Category: Array
Lead Author: Fowler N, et al.
Published Date: 09/03/2021
Download Link: https://ascopubs.org/doi/full/10.1200/JCO.20.03433
Download Text: Download
Popup Confirmation?:
site-sidebar-layout: default
ast-site-content-layout: default
site-content-style: default
site-sidebar-style: default
theme-transparent-header-meta: default
stick-header-meta: default
astra-migrate-meta-layouts: set
Scroll to Top